Bio-Techne Corporation develop, manufacture and sell life science reagents, instruments and services for the research, diagnostics and bioprocessing markets worldwide. The Company’s segments include Protein Sciences segment and Diagnostics and Spatial Biology segment. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. The Diagnostics and Spatial Biology segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, advanced tissue-based in-situ hybridization assays and instrumentation for spatial genomic and tissue biopsy analysis and genetic and oncology kits for research and clinical applications. Its product portfolio and application enable scientific investigations into biological processes and molecular diagnostics and progression of specific diseases.
BörsenkürzelTECH
Name des UnternehmensBio-Techne Corp
IPO-datumFeb 09, 1989
CEOKelderman (Kim)
Anzahl der mitarbeiter3100
WertpapierartOrdinary Share
GeschäftsjahresendeFeb 09
Addresse614 Mckinley Pl N E
StadtMINNEAPOLIS
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl55413
Telefon16123798854
Websitehttps://www.bio-techne.com/
BörsenkürzelTECH
IPO-datumFeb 09, 1989
CEOKelderman (Kim)